Compare LXRX to:
After Hours: 1.68 0.00 (0.00%) 4:34pm ET
| Last Trade: | 1.68 |
|---|---|
| Trade Time: | Feb 9 |
| Change: | |
| Prev Close: | 1.71 |
| Open: | 1.75 |
| Bid: | 1.60 x 1000 |
| Ask: | 1.99 x 100 |
| 1y Target Est: | 2.50 |
| Day's Range: | 1.65 - 1.76 |
|---|---|
| 52wk Range: | 0.81 - 3.78 |
| Volume: | 537,249 |
| Avg Vol (3m): | 766,575 |
| Market Cap: | 295.18M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.56 |
| Div & Yield: | N/A (N/A) |
| Wed, Feb 3 | Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor ConferencePR Newswire |
| Thu, Jan 28 | Will 'Knockout' Mice Make a Knockout Stock?Morningstar.com |
| Tue, Jan 26 | Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes TrialPR Newswire |
| Thu, Jan 21 | Wednesday's Biggest Stock Starsat Motley Fool |
| Thu, Jan 21 | Skymark Research Initiates Independent Research Coverage on Lexicon Pharmaceuticals, Inc.GlobeNewswire |
| Wed, Jan 20 | Wall St follows commodities sharply lowerat FT.com |
| Wed, Jan 20 | Lexicon shares up on good diabetes drug trialat bizjournals.com |
| Wed, Jan 20 | UPDATE - Lexicon diabetes drug meets mid-stage trial goalat Reuters |
| Wed, Jan 20 | Biotech Stocks: Drug stocks diverge; Shire, Lexicon in spotlightat MarketWatch |
| Wed, Jan 20 | Lexicon diabetes drug candidate meets study goalsAP |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.